Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for Stoke Therapeutics, Inc., €15k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Jonathan D Allan: trading record in brief
Jonathan D Allan is a declared insider of Stoke Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 16 June 2026 and 2 October 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 2 October 2026, reports a transaction of €15k in Stoke Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jonathan D Allan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
627 shares@ US$26.01CommonSEC144:0001950047-26-010004
1,457 shares@ US$30.000.0022% mcap100.0% of flowCommonSEC144:0001950047-26-006194
2 of 2 declarations
